In vitro inhibition of feline coronavirus replication by small interfering RNAs

Veterinary Microbiology

Volumn 150, Issue 3-4, 2011, Pages 220-229

  McDonagh, Phillip ^a   Sheehy, Paul A ^a   Norris, Jacqueline M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antiviral; Feline coronavirus; Feline infectious peritonitis; RNA interference; SiRNA

Indexed keywords

COMPLEMENTARY DNA; GENOMIC RNA; MESSENGER RNA; SMALL INTERFERING RNA; VIRUS DNA; VIRUS RNA;

5' UNTRANSLATED REGION; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CELL STRAIN; CONTROLLED STUDY; CORONAVIRUS; CRANDALL FELINE KIDNEY CELL; FELINE INFECTIOUS PERITONITIS; GENE EXPRESSION; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE; IN VITRO STUDY; NONHUMAN; NUCLEOCAPSID GENE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA SEQUENCE; VIRUS GENE; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; CATS; CELL LINE; CORONAVIRUS, FELINE; FELINE INFECTIOUS PERITONITIS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; VIRAL LOAD; VIRUS REPLICATION;

FELIDAE; FELINE CORONAVIRUS; FELINE INFECTIOUS PERITONITIS VIRUS;

EID: 79955970307     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2011.01.023     Document Type: Article

References (39)

1. Addie D.D., Jarrett J.O. Feline coronavirus antibodies in cats. Vet. Rec. 1992, 131:202-203.
2. Akhtar S., Benter I.F. Nonviral delivery of synthetic siRNAs in vivo. J. Clin. Invest. 2007, 117:3623-3632.
3. Barlough J.E., Scott F.W. Effectiveness of three antiviral agents against FIP virus in vitro. Vet. Rec. 1990, 126:556-558.
4. Barlough J.E., Shacklett B.L. Antiviral studies of feline infectious peritonitis virus in vitro. Vet. Rec. 1994, 135:177-179.
5. Behlke M.A. Progress towards in vivo use of siRNAs. Mol. Ther. 2006, 13:644-670.
6. Bell E.T., Toribio J.A., White J.D., Malik R., Norris J.M. Seroprevalence study of feline coronavirus in owned and feral cats in Sydney, Australia. Aust. Vet. 2006, J84:74-81.
7. Benson D.A., Karsch-Mizrachi I., Lipman D.J., Ostell J., Sayers E.W. GenBank. Nucleic Acids Res. 2010, 38:D46-D51.
8. Bitko V., Barik S. Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses. BMC Microbiol. 2001, 1:34.
9. Brown M.A., Troyer J.L., Pecon-Slattery J., Roelke M.E., O'Brien S.J. Genetics and pathogenesis of feline infectious peritonitis virus. Emerg. Infect. Dis. 2009, 15:1445-1452.
10. Cave T.A., Golder M.C., Simpson J., Addie D.D. Risk factors for feline coronavirus seropositivity in cats relinquished to a UK rescue charity. J. Feline Med. Surg. 2004, 6:53-58.
11. Chang H.-W., de Groot R.J., Egberink H.F., Rottier P.J.M. Feline infectious peritonitis: insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene. J. Gen. Virol. 2010, 91:415-420.
12. Dewerchin H.L., Cornelissen E., Nauwynck H.J. Replication of feline coronaviruses in peripheral blood monocytes. Arch. Virol. 2005, 150:2483-2500.
13. Ge Q., McManus M.T., Nguyen T., Shen C.-H., Sharp P.A., Eisen H.N., Chen J. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:2718-2723.
14. Groot-Mijnes J.D.F.d., Dun J.M.V., Most R.G.V.D., Groot F R.J.D. Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease. J. Virol. 2005, 79:1036-1044.
15. Hartmann K., Ritz S. Treatment of cats with feline infectious peritonitis. Vet. Immunol. Immunopathol. 2008, 123:172-175.
16. He M.L., Zheng B., Peng Y., Peiris J.S.M., Poon L.L.M., Yuen K.Y., Lin M.C.M., Kung H., Guan Y. Inhibition of SARS-associated coronavirus infection and replication by RNA interference. J. Am. Med. Assoc. 2003, 2665-2666.
17. He M.L., Zheng B.J., Chen Y., Wong K.L., Huang J.D., Lin M.C., Peng Y., Yuen K.Y., Sung J.J.Y., Kung H.F. Kinetics and synergistic effects of siRNAs targeting structural and replicase genes of SARS-associated coronavirus. FEBS Lett. 2006, 580:2414-2420.
18. Herrewegh A.A.P.M., Smeenk I., Horzinek M.C., Rottier P.J.M., Groot R.J.d. Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J. Virol. 1998, 72:4508-4514.
19. Holst B.S., Englund L., Palacios S., Renstrom L., Berndtsson L.T. Prevalence of antibodies against feline coronavirus and Chlamydophila felis in Swedish cats. J. Feline Med. Surg. 2006, 8:207-211.
20. Hsieh L.E., Lin C.N., Su B.L., Jan T.R., Chen C.M., Wang C.H., Lin D.S., Lin C.T., Chueh L.L. Synergistic antiviral effect of Galanthus nivalis agglutinin and nelfinavir against feline coronavirus. Antiviral Res. 2010, 88:25-30.
21. Hu W.Y., Myers C.P., Kilzer J.M., Pfaff S.L., Bushman F.D. Inhibition of retroviral pathogenesis by RNA interference. Curr. Biol. 2002, 12:1301-1311.
22. Jackson A.L., Linsley P.S. Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat. Rev. Drug Discov. 2010, 9:57-67.
23. Kahana R., Kuznetzova L., Rogel A., Shemesh M., Hai D., Yadin H., Stram Y. Inhibition of foot-and-mouth disease virus replication by small interfering RNA. J. Gen. Virol. 2004, 85:3213-3217.
24. Keyaerts E., Vijgen L., Pannecouque C., Van Damme E., Peumans W., Egberink H., Balzarini J., Van Ranst M. Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle. Antiviral Res. 2007, 75:179-187.
25. Kipar A., Baptiste K., Barth A., Reinacher M. Natural FCoV infection: cats with FIP exhibit significantly higher viral loads than healthy infected cats. J. Feline Med. Surg. 2006, 8:69-72.
26. Legendre A., Bartges J. Effect of Polyprenyl Immunostimulant on the survival times of three cats with the dry form of feline infectious peritonitis. J. Feline Med. Surg. 2009, 11:624-626.
27. Li B., Tang Q., Cheng D., Qin C., Xie F., Wei Q., Xu J., Liu Y., Zheng B., Woodle M. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat. Med. 2005, 11:944-951.
28. Li T., Zhang Y., Fu L., Yu C., Li X., Li Y., Zhang X., Rong Z., Wang Y., Ning H. siRNA targeting the leader sequence of SARS-CoV inhibits virus replication. Gene Ther. 2005, 12:751-761.
29. Martinez M.A., Clotet B., Este J.A., Martinez M.A., Clotet B., Este J.A. RNA interference of HIV replication. Trends Immunol. 2002, 23:559-561.
30. Masters P.S. The molecular biology of coronaviruses. Adv. Virus Res. 2006, 66:193-292.
31. Naito Y., Ui-Tei K., Nishikawa T., Takebe Y., Saigo K. siVirus: web-based antiviral siRNA design software for highly divergent viral sequences. Nucleic Acids Res. 2006, 34:W448-W450.
32. Pedersen N., Liu H., Dodd K., Pesavento P. Significance of coronavirus mutants in feces and diseased tissues of cats suffering from feline infectious peritonitis. Viruses 2009, 1:166-184.
33. Pedersen N.C. A review of feline infectious peritonitis virus infection: 1963-2008. J. Feline Med. Surg. 2009, 11:225-258.
34. Poland A.M., Vennema H., Foley J.E., Pedersen N.C. Two related strains of feline infectious peritonitis virus isolated from immunocompromised cats infected with a feline enteric coronavirus. J. Clin. Microbiol. 1996, 34:3180-3184.
35. Reed L., Muench H. A simple method of estimating 50 percent end-points. Am. J. Hyg. 1938, 27:493-497.
36. Rozen S., Skaletsky H.J. Primer3 on the WWW for general users and biologist programmers. Bioinformatics Methods and Protocols: Methods in Molecular Biology 2000, 365-386. Humana Press, Totowa, NJ. S. Krawetz, S. Misener (Eds.).
37. Shao Y., Chan C., Maliyekkel A., Lawrence C., Roninson I., Ding Y. Effect of target secondary structure on RNAi efficiency. RNA 2007, 13:1631.
38. Tompkins S.M., Lo C.-Y., Tumpey T.M., Epstein S.L. Protection against lethal influenza virus challenge by RNA interference in vivo. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:8682-8686.
39. Vennema H., Poland A., Foley J., Pedersen N.C. Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Virology (New York) 1998, 243:150-157.